The Nigerian Institute of Medical Research (NIMR) yesterday announced a significant achievement in its Safety and Antimicrobial Resistance of Mass Administration of Azithromycin, SARMAAN, project, saying about 1.4 million children under the age of five have been administered with Azithromycin.